Atrial Fibrillation Medications

40mg

indicated to manage ventricular and supraventricular arrhythmias to mitigate the risk of life-threatening heart rhythm irregularities.

0.25mg

Designed to support heart rhythm regulation, indicated to manage chronic heart failure.

2.5 · 5mg

utilized for stroke prevention to mitigate clotting risks.

100mg

developed to address cardiac rhythm irregularities, to mitigate potential complications.

150mg

intended to alleviate the risk of stroke and systemic embolism in atrial fibrillation.

50 · 100mg

Indicated for cardiac arrhythmias, formulated to target sodium channels and alleviate electrical instability to support a normal heart rhythm.

1 · 2 · 5mg

Formulated for thromboembolism to mitigate clotting risks.